Clinical Trial Update: Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 neoadjuvant trial evaluating nab-paclitaxel as chemotherapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Zhejiang University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN